Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant Recipient”

1,619 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,619 results

Testing effectiveness (Phase 2)Looking for participantsNCT04349436
What this trial is testing

A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaBasal Cell Carcinoma+1 more
Replimune Inc. 65
Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Post-approval studies (Phase 4)Looking for participantsNCT06044493
What this trial is testing

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 158
Large-scale testing (Phase 3)Looking for participantsNCT06407232
What this trial is testing

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Who this might be right for
Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison 90
Testing effectiveness (Phase 2)Study completedNCT01718743
What this trial is testing

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Study completedNCT01666951
What this trial is testing

Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 36
Post-approval studies (Phase 4)Active Not RecruitingNCT03266393
What this trial is testing

Envarsus XR® in Adolescent Renal Transplant Recipients

Who this might be right for
Kidney TransplantationRenal TransplantationGrafting, Kidney
University of California, Los Angeles 28
Not applicableStudy completedNCT01256255
What this trial is testing

Influenza Virus - A Multicenter Registry

Who this might be right for
Influenza Infection in Transplant Patients
University of Alberta 282
Testing effectiveness (Phase 2)Study completedNCT00266708
What this trial is testing

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

Who this might be right for
Renal Transplant Osteodystrophy
Montefiore Medical Center 60
Not applicableActive Not RecruitingNCT04945785
What this trial is testing

" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"

Who this might be right for
Renal Transplant Failure
Nantes University Hospital 226
Not applicableStudy completedNCT01271179
What this trial is testing

Study of Sequential Perfusion of Liver Grafts to Prevent Nonanastomotic Biliary Strictures After Liver Transplantation

Who this might be right for
Liver TransplantationTransplant Recipient
Shanghai Jiao Tong University School of Medicine 141
Not applicableEnded earlyNCT00504218
What this trial is testing

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
HypopituitarismHypogonadismThyroid Dysfunction+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 62
Post-approval studies (Phase 4)Study completedNCT02458417
What this trial is testing

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Who this might be right for
Segmental VitiligoPiebaldism
Netherlands Institute for Pigment Disorders 10
Post-approval studies (Phase 4)Study completedNCT01990118
What this trial is testing

Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients

Who this might be right for
End Stage Renal Failure
Penang Hospital, Malaysia 106
Not applicableStudy completedNCT02826213
What this trial is testing

Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient

Who this might be right for
TransplantationKidney
University Hospital, Tours 228
Testing effectiveness (Phase 2)Ended earlyNCT02991768
What this trial is testing

Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients

Who this might be right for
Diarrhea
University of Kansas Medical Center 9
Post-approval studies (Phase 4)Study completedNCT01802268
What this trial is testing

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Helio Tedesco Silva Junior 320
Post-approval studies (Phase 4)Study completedNCT04222023
What this trial is testing

Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.

Who this might be right for
Kidney Transplantation
University Hospital, Strasbourg, France 359
Not applicableStudy completedNCT05452317
What this trial is testing

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
CSL Behring 52
Post-approval studies (Phase 4)Active Not RecruitingNCT07274462
What this trial is testing

DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)

Who this might be right for
Microvascular Inflammation - MVI in Kindey Transplant Recipients
University Hospital, Martin 20
Load More Results